Global report - September 29, 2025
AstraZeneca switch to direct US listing, keeps UK listing
AstraZeneca plans to harmonize its share listing structure to deliver "a global listing for global investors in a global company".
Global report - September 22, 2025
Pfizer to acquire Metsera and its next-generation obesity portfolio
Pfizer will acquire all outstanding shares of Metsera common stock for USD 47.50 per share in cash at closing, representing an enterprise value of approximately USD 4.9 billion.
Collaboration - September 18, 2025
European partnership against antibiotic resistance to be launched
The European Partnership on One Health Antimicrobial Resistance (EUP OHAMR) will be launched at an event in Brussels on September 23.
Global report - August 22, 2025
EU, US trade statement: 15% tariffs on pharmaceuticals
The joint statement, released yesterday, confirms that cars, semiconductors, and pharmaceuticals will face a maximum 15% tariffs to enter the US.
Global report - August 6, 2025
USA: USD 500 million in funding for mRNA vaccine contracts canceled
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced the cancellation of contracts and grants earmarked for the development of mRNA vaccines.
Collaboration - July 30, 2025
The new European Life Science Strategy has been launched
Earlier this summer, the European Commission launched a new strategy to make Europe the most attractive place in the world for life sciences by 2030.
